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a b s t r a c t 
The N-terminal stretch of human frataxin (hFXN) intermediate (residues 42–80) is not conserved 
throughout evolution and, under deﬁned experimental conditions, behaves as a random-coil. Over- 
expression of hFXN56–210 in Escherichia coli yields a multimer, whereas the mature form of hFXN 
(hFXN81–210) is monomeric. Thus, cumulative experimental evidence points to the N-terminal moiety 
as an essential element for the assembly of a high molecular weight oligomer. The secondary structure 
propensity of peptide 56–81, the moiety putatively responsible for promoting protein–protein inter- 
actions, was also studied. Depending on the environment (TFE or SDS), this peptide adopts α-helical 
or β-strand structure. In this context, we explored the conformation and stability of hFXN56–210. The 
biophysical characterization by ﬂuorescence, CD and SEC-FPLC shows that subunits are well folded, 
sharing similar stability to hFXN90–210. However, controlled proteolysis indicates that the N-terminal 
stretch is labile in the context of the multimer, whereas the FXN domain (residues 81–210) remains 
strongly resistant. In addition, guanidine hydrochloride at low concentration disrupts intermolecular 
interactions, shifting the ensemble toward the monomeric form. The conformational plasticity of the 
N-terminal tail might impart on hFXN the ability to act as a recognition signal as well as an oligomer-
ization trigger. Understanding the ﬁne-tuning of these activities and their resulting balance will bear 
direct relevance for ultimately comprehending hFXN function. 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical 
Societies. Open access under CC BY-NC-ND license.. Introduction 
Macromolecular recognition is probably one of the most impor- 
ant subjects in biochemistry. Intriguing links exist among molecular 
ecognition, motions, stability, aggregation and biological function. 
oreover, there is a large number of examples that point out the im- 
ortance of structure ﬂexibility, local unfolding and the presence of 
ntermediate states in different biologically relevant processes, par- 
icularly those involving protein–ligand and protein–protein inter- 
ctions [ 1 –4 ]. In this context, it is very relevant to understand how 
hese interactions control the dynamics, ultimately affecting the na- 
ure of the ﬁnal ensemble responsible for the tertiary and quaternary * Corresponding author. Tel.: + 54 11 4964 8291x108; fax: + 54 11 4962 5457. 
E-mail addresses: delﬁno@qb.ffyb.uba.ar (J.M. Delﬁno) jsantos@qb.ffyb.uba.ar (J. 
antos). 
211-5463 c © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of Europ
ttp://dx.doi.org/10.1016/j.fob.2013.07.004 structure leading to protein function. 
In this regard, frataxin (FXN, a member of CyaY protein family), a 
∼130 residue protein with α/ β structure becomes a very interesting 
model. FXN acts as an iron chaperone and is crucially implicated in 
iron homeostasis in prokaryotes and in the mitochondria of eukary- 
otes. FXN is able to interact and transfer this metal to speciﬁc proteins, 
such as mitochondrial aconitase [ 5 ] and ferrochelatase [ 6 , 7 ], the latter 
being the key enzyme catalyzing the last step of heme biosynthesis. 
In its monomeric form, human FXN (hFXN) binds six iron atoms per 
protein molecule [ 8 ]. The deﬁciency of hFXN function is the cause of 
an autosomal recessive neurodegenerative disorder termed Friedre- 
ich’s Ataxia (FRDA), which leads to metabolic disorders, extensive cell 
damage by radical species, and impaired assembly of Fe–S clusters 
[ 9 , 10 ]. 
The 3D structure of hFXN has been determined by X-ray crystal- 
lography [ 11 ] and by NMR [ 12 ] and its backbone dynamics has been 
thoroughly analyzed by NMR [ 13 ]. Furthermore, thermodynamic sta- 
bility has been extensively investigated by temperature and chemical 
unfolding, proving that hFXN is a highly cooperative protein, with a ean Biochemical Societies. Open access under CC BY-NC-ND license.
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 stability of ∼7–8 kcal mol −1 [ 14 , 15 ]. However, stability of the FXN
domain varies signiﬁcantly among different organisms [ 16 ]. 
It has been established previously that yeast frataxin (yFXN) has
an N-terminal tail which ﬁnely modulates both the conformation of
the yFXN monomer and the assembly of its quaternary structure,
consisting of 48 subunits. The assembly of the biologically compe-
tent homo-multimeric form is induced by iron and results in a par-
ticle storing nearly 2400 iron atoms [ 17 ]. However, the ability of an
oligomerization-deﬁcient variant of yFXN to function in vivo suggests
that oligomerization-induced iron storage, is not a critical function
of this protein [ 18 ]. The role of the N-terminal region of hFXN is not
clear. Mitochondrial maturation of the human variant occurs via a
mechanism involving at least two-steps, the ﬁrst yielding the inter-
mediate hFXN42–210 which further matures to hFXN81–210 [ 19 ].
Variant hFXN56–210 was also detected in actively dividing cells by
high-resolution SDS–PAGE and Western blotting. In addition, it has
been shown that hFXN56–210 can be generated by proteolysis when
the primary 80–81 site is blocked [ 20 , 21 ]. The biological role of vari-
ants hFXN42–210 and 56–210 is not obvious and remains unknown.
FXN interacts with components of the Fe–S cluster biosynthesis ma-
chinery, such as proteins NFS1, ISCU and ISD11. No difference in the
interaction with ISCU and NFS1 was detected between the interme-
diate (GST-hFXN42–210) and the mature (GST-hFXN81–210) forms
of frataxin in pull-down experiments using mitochondria enriched
extracts, indicating that the site of interaction with the complex is
fully comprised within the sequence of the mature form [ 19 ]. How-
ever, some aspects of these interactions remain largely unclear. Very
recently, it has been suggested that the oligomeric form might play
a role in binding to the isolated components of the complex [ 17 ].
Two opposing views could be set in this scenario. Under particular
metabolic conditions, a longer N-terminus – that present in variants
starting at residue 42 or at residues 55–56 – might render FXN forms
endowed with the capacity to oligomerize. This would result in an en-
hanced iron detoxiﬁcation or iron storage activity in the cell. On the
other hand, as hFXN aggregation may take place via the N-terminal
peptide – bringing about an impairment of FXN function – cleavage
at position 80 would have been selected along evolution. 
It is worthy of note that two novel FXN isoforms (II and III) lack-
ing the mitochondrial signal peptide were detected and identiﬁed.
Variants II and III are speciﬁcally expressed in cerebellum and heart
tissues, respectively. Both proteins seem to be functionally relevant
and may be implicated in FRDA. Interestingly, isoform III lacks the 47
amino acid stretch between positions 9 and 55, a feature that resem-
bles it to hFXN56–210. Furthermore, based on the expression proﬁle,
it has been suggested that hFXN56–210 and isoform III share the same
iron-self processing mechanism [ 22 ]. 
The N-terminal sequence (residues 56–78) of hFXN is not con-
served throughout evolution. NMR experiments in solution sug-
gest that this segment is unstructured in the monomeric form, and
that its presence does not bear any effect on the protein struc-
ture [ 23 ]. However, during overexpression of hFXN56–210 in Es-
cherichia coli , oligomerization is clearly observed. Approximately 60–
70% of hFXN5–210 adopts a stable homo polymer conformation of
high molecular weight [ 23 , 24 ]. Moreover, supramolecular assembled
forms of hFXN have been isolated from human heart mitochondria
[ 21 ]. On the other hand, the recombinant variants hFXN80–210 and
hFXN90–210 lack the capability of oligomerization in physiological
buffers, and their hydrodynamic behavior corresponds to that ex-
pected for the monomer. Thus, the whole experimental evidence,
points to the N-terminal segment (residues 56–78) as a structural
element critical for the assembly of the high molecular weight multi-
mer. 
The origin of hFXN self recognition as well as the physicochemi-
cal conditions which favor the assembly process remain unknown. In
this context, we undertook the study of the homo-oligomerization of hFXN, inquiring on the importance of the protein surfaces involved
[ 25 , 26 ], whether this process is cooperative and if protomers share
features of the native state. In this paper, we focus on the speciﬁc
role of the N-terminal region in the in vitro homo-oligomerization
process. We suggest that the N-terminal tail may participate in the
stabilization of a competent state for oligomerization, establishing
crucial interactions removable by limited proteolysis or by the ad-
dition of a chaotropic agent. In so doing, data presented herein also
shed light on the folding process of variant hFXN56–210. 
2. Results 
Recombinant hFXN56–210 and hFXN90–210 variants were pu-
riﬁed as described in Section 4 . Their masses (17,253 ± 2 and
13,603 ± 2, respectively) differ in less than 3 Da by comparison to the
expected masses deduced from the hFXN sequence. Variant hFXN90–
210 conserves its N-terminal Met residue, whereas hFXN56–210 loses
it during expression in E. coli . Both proteins are expressed at high level
and mostly partition in the soluble fraction after cell disruption and
centrifugation (data not shown). Proteolytic damage is evident only in
the case of variant hFXN56–210 in E. coli lysates. Neither hFXN90–210
nor hFXN56–210 seem to contain signiﬁcant iron after puriﬁcation,
as judged by the 1,10-phenanthroline method. 
2.1. Oligomerization state of hFXN variants inferred from the 
hydrodynamic behavior 
To study the oligomerization state of recombinant hFXN56–210
we investigated the hydrodynamic behavior of both proteins using
SEC-FPLC ( Fig. 1 ). Variant hFXN56–210 elutes in the exclusion volume
( V O ) of the columns (Sephacryl S200 and Superose S200), indicating
the high molecular weight of the soluble multimer form. On the other
hand, the behavior of hFXN90–210 in aqueous solution corresponds to
that of an exclusively monomeric species, as it was similarly observed
for the mature form hFXN81–210 [ 23 ]. In addition, at 100 mM NaCl
the elution volume of the shorter variant is slightly lower than that
expected from its molecular weight (data not shown). This effect is
corrected at higher salt concentrations (e. g. 1.0 M NaCl). We suggest
that the electrostatic effect due to the acidic nature of the surface of
this protein may add to the exclusion of the protein from the matrix.
This behavior has been observed in our lab for other acidic proteins,
like fogrin [ 27 ]. 
Then, we asked ourselves whether a low concentration of
chaotropic agent may induce the disassembly of the multimer. When
hFXN56–210 was incubated in 1.5 M GdmCl and injected into the
SEC-FPLC system equilibrated in buffer at the same concentration of
GdmCl, essentially all the molecules turned into a slightly expanded
monomeric conformation, as revealed by the somewhat lower exclu-
sion volume measured for this form as compared with that expected.
In addition, to test if, after removal of the chaotrope, reassembly oc-
curs into an oligomeric conformation in vitro , we incubated hFXN56–
210 for 16 h in 1.5 M GdmCl, followed by exhaustive dialysis for 36 h at
4 ◦C ( Fig. 1 ). After this treatment, re-association of hFXN56–210 into
a soluble multimer of high molecular weight is evident ( Fig. 1 ). How-
ever, a fraction of molecules remains as monomeric species, pointing
to the complexity and lack of completeness of the oligomerization
process. Similarly, when hFXN56–210 was incubated in 1.5 M GdmCl
for 16 h, but injected into the SEC-FPLC system equilibrated in buffer
without GdmCl, both monomeric ( R S = 20.4 ± 0.5 A˚) and oligomeric
forms ( R S > 90 A˚) are present in signiﬁcant amounts. Despite the fast
dilution experienced by the sample, under these circumstances close
to 60% of the protein is able to achieve the oligomeric state in vitro
( Fig. 1 ). The remaining monomeric fraction elutes similarly to the
monomeric form of variant hFXN56–210 puriﬁed from E. coli (upper
panel in Fig. 1 ). Mass spectrometry conﬁrms that protein samples do
not undergo proteolysis at any step along these treatments. This is
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Fig. 1. Hydrodynamic behavior of protein constructs studied by size exclusion chro- 
matography (SEC). Lower panel: proteinhFXN56–210 innative condition (the oligomer, 
grey line) or after incubation in 1.5 M GdmCl and subsequent dialysis (black line). In 
addition, a protein sample was injected after incubation in 1.5 M GdmCl without the 
dialysis step and the column was equilibrated in the presence of 1.5 M GdmCl (black 
dashed line) or in the absence of denaturant (grey dashed line). Upper panel: as control 
samples, hFXN90–210 and monomeric hFXN56–210 were also run. In all cases buffer 
was 20 mM Tris–HCl, 100 mM NaCl, 1 mM EDTA, pH 7.0 and runs were performed at 
room temperature. 
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Fig. 2. Spectroscopic characterization of hFXN variants. (A) Far-UV CD; (B) near-UV 
CD; (C) Trp ﬂuorescence emission (the excitation wavelength is 295 nm); (D) fourth- 
derivative UV-absorption; and (E) ANS ﬂuorescence emission (the excitation wave- 
length is 350 nm). Both proteins hFXN90–210 and hFXN56–210 are in buffer 20 mM 
Tris–HCl, 100 mM NaCl, 1 mM EDTA, pH 7.0 at 20 ◦C. articularly important to note, because of the known lability of this 
ariant in the monomeric state. 
Taken together, these results indicate that the N-tail of the pro- 
ein contains in its sequence the information to promote those inter- 
olecular interactions necessary for the assembly of the oligomeric 
orm. Thus, oligomerization is not the result of recombinant over- 
xpression of the protein. 
.2. Optical characterization of the homo-oligomeric form of hFXN 
To investigate secondary and tertiary structure content of the re- 
ombinant oligomeric form of hFXN56–210, we carefully compared 
he circular dichroism spectra corresponding to hFXN56–210 in its 
ligomeric form with that of monomeric hFXN90–210 ( Fig. 2 ). CD 
ain signals in the far-UV region of the variants are very similar, 
lthough at 230 nm dichroic absorbance of aromatic residues might 
ontribute to the spectrum of hFXN90–210 ( Fig. 2 A). Correspond- 
ngly, the near-UV CD spectrum of the shorter variant shows an en- 
anced ﬁne-structured pattern of aromatic bands ( Fig. 2 B). The de- 
rease in intensity of the signals in this range for hFXN56–210 in 
he oligomeric form might reﬂect changes in the close environment 
f the aromatic side-chains or conformational diversity among sub- 
nits. Interestingly, these results might be compatible with changes 
n tertiary structure of the frataxin domain, including the stabilization 
f a molten-globule like conformation in the oligomeric context. 
As mentioned previously, although variant hFXN56–210 ex- 
ressed in E. coli yields mainly the oligomeric form, nearly 30% of 
he protein remains as soluble monomer [ 24 ]. Taking into account 
his fact, we puriﬁed the latter form to compare its spectral features 
ith those of the oligomer and hFXN90–210 ( Fig. S1 ). It is evident that monomeric hFXN56–210 yields a far UV CD spectrum which is 
practically superimposable to that observed for hFXN90–210, includ- 
ing the contribution of the aromatic band at 230 nm. In the same 
fashion, the near-UV CD spectrum of the monomer bears more re- 
semblance to that of variant hFXN90–210 than to hFXN56–210 (data 
Santiago E. Faraj et al. / FEBS Open Bio 3 (2013) 310–320 313 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Limited proteolysis of hFXN variants. Both hFXN90–210 and hFXN56–210 were 
incubated with trypsin 1:100 (protein to protease mass ratio) at 20 ◦C, in 20 mM Tris–
HCl, 100 mM NaCl, 1 mM EDTA, pH 7.0. Aliquots were separated at different times (0, 
1, 2, 4 and 20 h) and the reaction was immediately stopped by the addition of 2 ×
SDS–PAGE sample buffer. Samples were kept at −20 ◦C until loaded into the gel (upper 
panel). Products were also analyzed by SEC-FPLC (lower panel) and the integrity of the 
covalent structure of the protein samples was checked by ESI-MS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 not shown). Remarkably, the calculated spectral difference ( S oligomer –
S monomer ) suggests the acquisition of additional secondary structure
in the context of the oligomer. In addition, the lower signal measured
below 208 nm for monomeric hFXN56–210 by comparison with the
oligomer points to the contribution of a random-coil conformation of
the N-tail to the spectrum of the former. 
The ﬂuorescence spectra of hFXN56–210 and hFXN90–210 show
a similar maximal wavelength of emission ( Fig. 2 C). Nevertheless,
the former exhibits enhanced quenching, probably related to its
multimeric state. Likewise, both forms show almost superimposable
fourth-derivative absorption spectra ( Fig. 2 D). Particularly, bands cor-
responding to Trp are slightly red-shifted: 292.8 and 285.7 nm for
hFXN56–210, and 292.6 and 285.5 nm for hFXN90–210. By compar-
ison, N-acetyl-tryptophanamide (NATA) – a model compound of full
solvent exposure for Trp – shows bands at 289.1 and 282.1 nm. For
both variants, these data indicate a deﬁnite apolar environment for
this aromatic residue. 
The existence of solvent exposed apolar surfaces in the oligomeric
state of hFXN56–210 was revealed by the ﬂuorophore ANS. Fig. 2 E
shows that – although ANS does not attach to hFXN90–210 – the
probe is able to bind hFXN56–210 in the oligomeric form. Binding of
this dye to accessible native surfaces has been well documented, e.g.
as in the case of BSA [ 28 ] and FABP [ 29 ]. Nevertheless, binding to a
partially structured N-tail in hFXN56–210 or to sites present in a less
compact molten globule like state cannot be underestimated. 
2.3. Oligomer disassembly by proteolysis: the C-terminal domain of 
hFXN56–210 is resistant to proteolysis 
The lower magnitude of signals in the near-UV CD region ob-
served for the oligomer, by comparison with variant hFXN90–210,
and the presence of signiﬁcant binding of ANS to the former might
be attributed to a less rigid environment around the aromatic chro-
mophores and the appearance of exposed hydrophobic patches to
the aqueous solvent in the quaternary assembly. However, multi-
meric hFXN56–210 proves to be soluble and resistant to proteolysis
when expressed in E. coli . This fact led us to hypothesize that both
the N-terminal tail and the C-terminal domain of this form remain
well-folded and / or inaccessible to proteases in the supramolecular
assembly. Thus, it becomes of key importance to investigate the ex-
tent of structure in the oligomer. 
Limited proteolysis in vitro followed by SDS–PAGE and SEC-FPLC
shows that upon incubation with trypsin (1:100, mass ratio, protease
to protein) the oligomer hFXN56–210 disassembles, as hFXN56–210
molecules become shortened to the form hFXN81–210. Proteolysis
does not proceed beyond the latter ( Fig. 3 ). In all likelihood, this
fact indicates that the FXN domain is well-folded. Most signiﬁcantly,
resistance to proteolysis is a distinguishing feature of native state
hFXN90–210 ( Fig. 3 , top right panel). This evidence suggests that the
N-terminal moiety of hFXN56–210 is only partially structured, there-
fore, to some extent exposed to protease action. Similarly, challenging
variant hFXN90–210 with chymotrypsin reveals limited susceptibil-
ity to proteolysis, as evidenced by a single point cut at residue Tyr 205
after incubation for 4 h at 20 ◦C [ 15 ]. 
2.4. Incubation of hFXN56–210 with GdmCl triggers the disassembly of 
the oligomer 
To further investigate the conformation of variant hFXN56–210,
we tested its chemically induced unfolding ( Fig. 4 ). In particular, we
evaluated the cooperativity of the transition observed by (i) the mag-
nitude observed for the parameter m NU , that discloses the dependence
of the free energy difference of unfolding with denaturant concentra-
tion, and (ii) the extrapolated G ◦NU, H20 value, measuring the stabil-
ity of hFXN56–210 by comparison with the hFXN90–210 variant. The SEC experiment allowed us to distinguish the occurrence of
two separate phenomena, namely, (i) the disassembly of the oligomer,
most likely not a fully reversible process, as judged by partial re-
association after dialysis, from (ii) the subsequent reversible un-
folding of the monomeric species (see below). Regarding the hy-
drodynamic behavior of hFXN ( Fig. 4 ), at 1.0 M GdmCl, more than
50% of the oligomer dissociates into a monomer characterized by
a R S = 20.5 ± 0.1 A˚, essentially identical to that expected for a
globular species of the molecular mass corresponding to that of
monomeric FXN56–210 ( R S = 20.3 A˚, according to Uversky [ 30 ], Figs.
4 A and S2 ), and slightly larger than that measured for hFXN90–210
( R S = 18.9 ± 0.1 A˚). In addition, at 1.0 M GdmCl a slight but sig-
niﬁcant increase in the Trp ﬂuorescence emission and a red shift of
the maximum occurs ( Figs. 4 C and S3A ), probably indicating a per-
turbation in the closed-packed environment around these aromatic
residues. This is not the case for hFXN90–210 ( Fig. S3D ). Naturally, at
this GdmCl concentration range, observations might be governed by
the changes in the oligomeric state of the protein. In this regard, at
1.5 M GdmCl ∼100% of molecules populate a monomeric conforma-
tion ( Fig. 4 A). The presence of oligomeric and / or eventually partially
folded species in the conformational ensemble of hFXN56–210 are re-
vealed by the binding of ANS. By contrast, at all GdmCl concentrations
assayed hFXN90–210 fails to bind this ﬂuorophore ( Fig. 4 D). 
In a different vein, between 1 and 2 M GdmCl a signiﬁcant in-
crease in the elution volume – compatible with the expansion of the
monomeric form – is observed for hFXN56–210: the R S values derived
are 22.6 ± 0.2 and 24.0 ± 0.1 A˚, for 1.5 and 2.2 M, respectively. As
the perturbation in the elution volume at this GdmCl concentration
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Fig. 4. Chemical unfolding of hFXN variants followed by (A) SEC-FPLC, (B) CD signal at 
220 nm, (C) Trp ﬂuorescence emission intensity at 320 nm, and (D) ANS ﬂuorescence 
emission intensity at 480 nm. Variant hFXN90–210 is indicated in open symbols ( ©) 
and hFXN56–210, in ﬁlled symbols ( •). Unfolding of hFXN56–210 was achieved by 
incubation for 16 h at room temperature. Buffer was 20 mM Tris–HCl, 100 mM NaCl, 1 
mM EDTA, pH 7.0 and measurements were performed at 20 ◦C. For the R S estimations by 
SEC (Sephacryl S-200), a calibration curve (log R S vs. V e ) with proteins of known R S was 
carried out and NaCl solutions of different ionic strength were assayed (from 100 mM 
to 1.0 M, data not shown). Unfolding data corresponding to CD and Trp ﬂuorescence 
for variant hFXN90-210 was extracted from [ 15 ]. range is much less evident in the case of hFXN90–210, we suggest 
that the changes observed might be related to the unfolding and the 
concomitant increased solvation of the 34-residue N-terminal stretch, 
although more experiments should be designed to clarify this point. 
The integrity of all species was ascertained by ESI-MS after incubation 
for 16 h in 0, 1.0, 1.5, and 2.0 M GdmCl solutions. Proteolysis was not 
detected in either of these conditions. 
At higher GdmCl concentrations (2–3 M), a major change in 
the elution volume is observed for both variants hFXN56–210 and 
hFXN90–210 ( Fig. 4 A). This represents a progressive evolution in the 
elution volume giving rise to very sharp peaks, and values of the hy- 
drodynamic radius that do not correspond to either that expected 
for the native or the completely unfolded states: e.g. at 2.6 M, the 
R S values for hFXN56–210 and hFXN90–210 are 29.0 ± 0.1, and 
25.0 ± 0.1 A˚, respectively ( Fig. S2 ). On the other hand, the R S observed 
for hFXN56–210 and hFXN90–210 at 4.0 M GdmCl are 33.4 ± 0.1, and 
30.0 ± 0.1 A˚, respectively. This result is consistent with the GdmCl- 
induced unfolded state of hFXN co-existing in fast equilibrium with 
the native state. The conformational transitions observed for each 
variant between 2 and 3 M GdmCl superimpose well, exhibiting com- 
mon trends: decreases in the far-UV CD signal and in the Trp ﬂu- 
orescence intensity, the latter also associated to an important red 
shift of the wavelength of maximum emission ( Fig. 4 B and C). This 
result is compatible with a major conformational change in tertiary 
and secondary structures. The global interpretation of the SEC and 
spectroscopic data in the range 2–3 M GdmCl points to a transition 
dominated by the unfolding of the monomeric form of hFXN56–210 
( Figs. 4 , S2 and S3 ). 
The interpretation of this body of results can be achieved in the 
simplest fashion by assuming a model for the dissociation / unfolding 
where the species present are the oligomer, the monomer and the un- 
folded state. Unfortunately, the partial irreversibility observed for the 
oligomer disassembly process taking place in the range 0 to ∼1.0 M 
GdmCl precluded a rigorous thermodynamic treatment of this part 
of the data. One should also take into account the fact that the ob- 
served changes associated to the major transition (that occurring in 
the range 1.5–4.0 M GdmCl) comply with full reversibility and in- 
volve only monomeric and unfolded states. Thus, the derived ther- 
modynamic parameters for variants hFXN56–210 and hFXN90–210 
were calculated and summarized in Table 1 . Remarkably, the unfold- 
ing curve corresponding to the monomer of hFXN56–210, as puriﬁed 
from E. coli extracts in the monomeric form, is essentially superim- 
posable to that observed for the variant puriﬁed as the oligomeric 
species ( Fig. S4 ). Regardless of its source, once hFXN56–210 adopts a 
monomeric state, it unfolds with a similar difference in free energy as 
hFXN90–210. In regard to this point, the mass of the monomeric form 
was checked by ESI-MS to check the integrity of the protein (data not 
shown). 
2.5. Isolated peptide hFXN56–81 acquires structure in TFE and SDS 
solutions 
As secondary structure predictions by Jpred3 [ 31 ] carried out on 
the sequence of hFXN uncovers a moderate tendency to form α-helical 
(residues 59–70) and β-strand (residues 72–79) structures ( Fig. S5A ), 
we decided to study the propensity of the N-terminal tail of hFXN 
(represented by peptide hFXN56–81) to acquire secondary structure 
in isolation. 
As judged by the shape of the far-UV CD spectrum, the synthetic 
peptide hFXN56–81 is unstructured in its isolated form ( Fig. 5 A). How- 
ever, after incubation with the co-solvent 2,2,2-triﬂuoroethanol (TFE), 
the far-UV CD spectrum becomes compatible with the stabilization 
of α-helical structure, as indicated by the appearance of the negative 
bands at 208 and 220 nm, Fig. 5 A. The ellipticity observed in 30% TFE 
solution is approximately 37% of the total signal expected for a full 
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Table 1 
GdmCl-induced unfolding parameters for the hFXN variants. a 
hFXN Fluorescence Circular dichroism 
G ◦NU H 2 O m NU C mNU G 
◦
UN H 2 O m NU C mNU 
90–210 6.7 ± 0.2 2.9 2.3 ± 0.1 6.7 ± 0.2 2.9 2.3 ± 0.1 
O-56–210 b 6.4 ± 0.1 2.8 ± 0.3 2.3 ± 0.2 6.1 ± 0.8 2.8 ± 0.4 2.2 ± 0.3 
m-56–210 c 6.5 ± 0.5 2.9 ± 0.3 2.2 ± 0.4 6.3 ± 0.1 2.9 ± 0.4 2.2 ± 0.3 
a A two-state N ↔ U model is assumed. Parameter m NU is the slope of the linear dependence of free energy of unfolding ( G ◦NU ) on denaturant concentration, and G ◦NU H2O 
represents the extrapolated value of G ◦NU at zero denaturant concentration. In the ﬁttings corresponding to variant hFXN90–210, we used the predicted m NU value for GdmCl- 
induced unfolding, considering a globular protein of identical molecular weight: 2.9 kcal mol −1 M −1 for hFXN90–210. The units of m NU are kcal mol −1 M −1 . C m and free energy 
are in M and kcal mol −1 , respectively. The parameters for hFXN56–210 were calculated by non-linear least-square ﬁtting of the model to the data shown in Fig. 5 , as described in 
Section 4 and ﬁtting for hFXN90–210 is the same as in Ref. [ 15 ]. 
b Variant hFXN56–210 expressed in E. coli yields mainly the oligomeric form (O-hFXN56–210). In this case this fraction was puriﬁed from E. coli extracts and analyzed. 
c When hFXN56–210 is expressed in E. coli, nearly 30% of the recombinant protein remains as soluble monomer (m-hFXN56–210). In this case this fraction was puriﬁed and 
analyzed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 α-helix. Accordingly, the AGADIR algorithm [ 32 , 33 ] predicts a some-
what stable α-helical structure in the N-tail ( Fig. S5 B). Remarkably,
when sequence 56–90 was submitted to the I-TASSER server, an inte-
grated platform for automated protein structure prediction [ 34 ], the
stretch 59–70 was also predicted to fold as an α-helix in all ﬁve 3D
models presented as the output (data not shown). 
In addition, we analyzed whether the detergent sodium dodecyl
sulfate (SDS) is able to stabilize a structured conformation. Strikingly,
in the presence of SDS (0.5–2 mM), spectra are characterized by a sin-
gle negative band at 216 nm, a feature compatible with the existence
of β-strands ( Fig. 5 B). It is noteworthy that in the case of the syn-
thetic peptide corresponding to the amphipathic C-terminal α-helix
of hFXN (residues 181–195), SDS is indeed able to stabilize the helical
conformation [ 35 ]. 
Taking advantage of the presence of the intrinsic probe Trp66 in
hFXN56–81, we also studied the ﬂuorescence emission in TFE or SDS
to establish whether this reporter residue is able to sense changes
in the chemical environment ( Fig. 5 C). In the absence of co-solvent,
emission shows λMAX = 351 nm, indicating a polar milieu around the
ﬂuorophore. On the other hand, both co-solvents TFE and SDS produce
signiﬁcant blue shifts (4 and 19 nm, respectively). As a control sample,
we studied the ﬂuorescence emission of N-acetyl- l -tryptophanamide
(NATA) under the same experimental conditions. Clearly, the change
in the environment of Trp66 depends on the polypeptide context of
hFXN56–81, since hardly any change occurs for NATA. Signiﬁcantly,
the presence of SDS not only results in the shift, but also causes a
dramatic quenching effect. This behavior may result primarily as the
consequence of SDS / Trp side-chain interaction, not excluding an en-
vironmental alteration brought about by an SDS-induced change in
the conformation of the peptide. These results agree well with the
notion that the N-terminal tail might acquire a structured conforma-
tion upon interaction with protein apolar surfaces of hFXN56–210, or
even with other protein partners inside the cell. 
2.6. Interaction between peptide hFXN56–81 and hFXN 
To establish whether peptide hFXN56–81 is able to interact with
hFXN, and whether this interaction guides the folding of the N-
terminal peptide, and assuming that residues 81–89 are most likely
unstructured [ 23 ], we evaluated changes in the far-UV CD spectrum
upon mixing the above peptide with protein hFXN90–210. After in-
cubation for 1 h at room temperature, the spectrum of this mixture
was compared with the calculated sum of the spectra of each com-
ponent in isolation (15 μM ﬁnal concentration). Under these condi-
tions, no change was detected in the CD signals (not shown), a result
that agrees with NMR evidence by Prischi et al. [ 23 ], where chemical
shifts compatible with a random coil are observed for residues 56–
80 in the context of monomeric hFXN56–210. Interestingly, whenpeptide hFXN56–81 and hFXN90–210 are incubated (at a 10:1 pep-
tide:protein molar ratio) with the dye ANS, an enhancement of ﬂuo-
rescence at 480 nm was observed ( Fig. S6A ). On the other hand, the
incubation of peptide (50 μM) or protein hFXN90–210 (5 μM) in iso-
lated form does not yield signiﬁcant change in the ANS ﬂuorescence
spectrum. These results may put forward the notion that peptide and
protein may indeed interact, giving rise to the emergence of new
exposed apolar surfaces. However, the absence of ANS binding at a
low peptide:protein ratio suggests the weak nature of the interaction
between both moieties (data not shown). In this context, one should
note that hFXN56–210 as a monomer shares the capability with the
complex of binding this ﬂuorescent dye ( Fig. S6B ). One could specu-
late that the conformation of residues 56–81 may be constrained by
the presence of the hFXN domain, particularly when the N-terminal
peptide is covalently bound to the rest of the protein. 
We proceeded to investigate whether peptide hFXN56–81 is able
to disassemble the quaternary structure of hFXN56–210 -perhaps by
interacting with the N-terminal tail of the protomers in the context of
the oligomer. Surprisingly, when peptide hFXN56–81 was added to a
solution of the soluble multimer form of hFXN56–210, the aggrega-
tion into an insoluble species of this protein was triggered, as judged
by the onset of turbidity and the quantitative assessment by cen-
trifugation followed by SDS–PAGE ( Fig. 6 ). This result demonstrates
that peptide hFXN56–81 is capable of satisfying key contacts with
the oligomer leading to the assembly of large aggregates. In the same
fashion, when hFXN56–210 was submitted to the server PASTA (Pre-
diction of Amyloid Structure Aggregation [ 36 ]) we found that the
stretch of 14 residues 65–78 ( Fig. S7 ) would form a seed for oligomer-
ization, adopting a parallel β-strand conformation like that occurring
in a ﬁbril core. 
Finally, we explored whether hFXN56–210 in the monomeric state
(6.0 μM protein concentration) may alter its propensity to aggregate
upon addition of 20% TFE. If this were the case – and hFXN90–210 did
not aggregate under the same experimental conditions – we might
correlate the tendency of hFXN to aggregate with the presence of the
N-tail and the conformational change that might be taking place in
this region of the protein. Interestingly, TFE does not produce sig-
niﬁcant changes in the far-UV CD spectrum of hFXN90–210 and the
protein remains completely soluble (data not shown), whereas af-
ter addition of TFE variant hFXN56–210 aggregates into an insoluble
form, as judged by UV absorption (data not shown). Taking together,
these results are compatible with the existence of a conformational
change involving the N-tail of the protein that could alter the dynam-
ics and the quaternary structure of hFXN. 
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Fig. 5. Peptide hFXN56–81 acquires structure in the presence of co-solvents. Synthetic 
peptide was incubated with TFE (A, 0, 10, 20, or 30%, v / v) or SDS (B, 0, 0.5, 1.0, 1.5 
and 2.0 mM). Far-UV CD (A and B) and Trp ﬂuorescence (C) spectra were acquired. 
NATA (N-acetyl tryptophanamide) was included as a reference compound. Excitation 
wavelength was 295 nm and buffer was 20 mM Tris–HCl and 100 mM NaCl, 1 mM 
EDTA, pH 7.0. 
Fig. 6. Aggregation of hFXN56–210 induced by the N-terminal peptide hFXN56–81. 
Variants hFXN90–210 and hFXN56–210 were incubated at 37 ◦C in the presence or in 
the absence of peptide hFXN56–81 (1:10, protein:peptide molar ratio) in buffer 20 mM 
Tris–HCl, 100 mM NaCl, 1 mM EDTA, pH 7.0. Aliquots were taken at different incubation 
times (0, 1, 5 and 20 h). Samples were centrifuged for 10 min at 4 ◦C, the soluble and 
the insoluble fractions were isolated and the reaction was immediately stopped by 
addition of 4 × SDS–PAGE sample buffer. The samples were ﬁnally loaded onto a 16% 
gel. Separated bands (upper panel) and their quantiﬁcation after Coomassie Brilliant 
Blue staining (lower panel) at each indicated time are shown. Errors were estimated at 
less than 10%. 3. Discussion 
NMR studies showed that the N-terminal chain of hFXN56–210 
adopts a random-coil state, as indicated by the analysis of the chemi- 
cal shift of signals assigned to this part of the backbone [ 23 ]. Most im- 
portantly, these observations were gathered on the monomer species 
of this variant, where the hFXN domain shows chemical shifts close to 
those of native hFXN90–210. Likewise, the analysis of the amino acid 
sequence 56–80 shows low secondary structure propensity. However, 
this could represent a common attribute of several polypeptide chains 
that acquire structure upon interacting with their cognate partners, 
as is the case of several intrinsically disordered proteins (IDPs). In this 
scenario, an in-depth structural study of this part of the protein is 
needed to reach a thorough understanding of the molecular details 
of this key biological phenomenon underlying FRDA. Particularly re- 
vealing are the electrostatic properties of the N-terminal sequence of 
hFXN56–210. A net charge of + 5 indicates that this peptide might in- 
teract with negatively charged segments located further down along 
the sequence, like the ones existing at the iron binding site ( α-helix 
1, loop1 and β-strand 1, Fig. S5 ). Suggestively, Kondapalli and co- 
workers [ 37 ] showed that for residues 54, 58, 60, 62, 66, 69 and 70, 
chemical shift values appear to be dispersed in the HSQC spectrum, 
even though a deﬁned kind of secondary structure cannot be assigned 
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 to this section of the backbone. In the same fashion, the analysis of mu-
tual information in the CyaY protein family points to the co-evolution
of several residue positions belonging to this same stretch, a fact that
might indicate a tendency to acquire local structure (positions 23, 51,
52, 53, 55, 58, 61, 62, 63, 64, 65, 66 and 70, plus 196, cluster B in Fig.
S8 ). 
It is noteworthy that residues 80–90 of the mature form of hFXN
are predicted as random coil, in accord with the analysis of chemical
shifts, most likely indicating that this segment is unstructured [ 37 ],
[ 23 ]. In this context, we believe that this amino acid stretch may act
as a linker exposing a site for proteolysis at position 81 ( Fig. S5 ). 
The biophysical characteristics of hFXN56–210 explored in this
work – including UV absorption, CD and ﬂuorescence spectroscopies,
and the hydrodynamic behavior – indicate that the multimeric form
is indeed structured and its constituent monomers display a coopera-
tive unfolding transition that differ only marginally from hFXN90–210
( G  °N U H 2 O 
are 6.3 and 6.7 kcal mol −1 , respectively), with a value for
the m NU parameter (2.8 ± 0.3 kcal mol −1 M −1 ) closely resembling
that corresponding to the hFXN domain. This suggests that in the
range of 1.5–3 M GdmCl concentrations corresponding to the unfold-
ing transition, the N-terminal tail does not pack well onto the folded
FXN domain, because typically the predicted m NU for a globular pro-
tein of this size should be ∼3.8 kcal mol −1 M −1 , a value considerably
larger than that experimentally measured here. 
The existence of solvent exposed apolar surfaces in the oligomeric
state of hFXN56–210 is revealed by the binding of the ﬂuorophore
ANS. This phenomenon points to the presence of partially folded con-
formations in the context of the oligomer. In the same way, the de-
creased intensity of the near-UV CD signals for hFXN56–210 in the
oligomeric form might reﬂect conformational heterogeneity among
subunits with molten globule-like dynamics. However, hFXN56–210
unfolds in a cooperative fashion showing similar stability to the ob-
served for variant hFXN90–210, pointing to the fact that confor-
mational differences between oligomer subunits and the monomer
should not be drastic. This is also in agreement with the reduced sen-
sitivity to proteolysis observed for the subunits of the oligomer. This
feature clearly distinguishes its nature from that of a typical molten-
globule, or even from other destabilized native-like states of hFXN,
as is the case for the C-terminal truncated variant of human frataxin
hFXN90–195 [ 15 ]. 
The oligomerization process of hFXN shows distinctive features:
(i) in contrast to the yFXN, where this phenomenon is triggered by
iron, puriﬁed monomeric fractions of forms hFXN56–210 [ 24 ] and
hFXN42–210 [ 37 ] do not appear to assemble into oligomers in vitro
under native conditions; (ii) it was shown that large oligomers of
hFXN can be irreversibly disassembled into stable monomers by the
addition of SDS [ 38 ]; (iii) we show herein that monomeric species of
hFXN56–210 stabilized by incubation at moderate concentrations of
denaturant (1.5 M GdmCl) can reassemble into the oligomeric form
upon dialysis or by removal of GdmCl by gel ﬁltration (SEC). Taken
together, these results allowed us to draw the following picture. Lim-
ited conformational changes on the native-state facilitated by the
chaotropic agent, promote oligomer assembly from the monomeric
form of hFXN56–210, which becomes competent for oligomerization
(monomer OC ). 3.1. Unfolded state 
In this scenario, the N-terminal tail of hFXN56–210 seems to be
an essential key conferring the protein the capability to oligomerize.
Moreover, the oligomeric form of hFXN56–210 may disassemble into
native monomers by a protease treatment removing the N-terminal
extension, while maintaining intact the rest of the protein. This fact
supports the idea that the N-terminal region mediates the interac-
tion among subunits, and indicates that this moiety is most likely
exposed to the solvent, and – as such – to protease action. The latter
indicates that sequence 56–81 must be covalently bound to the rest
of the protein to promote the oligomerization of the hFXN domain.
Independently, the non-covalent interaction between the N-terminal
tail and the rest of the protein is also possible, as revealed by the
ANS binding to the complex hFXN90–210 / hFXN56–81 and the on-
set of aggregation of hFXN56–210 triggered by the addition of excess
amounts of peptide hFXN56–81. 
Regarding the homologue of frataxin yFXN, studies performed by
Karadaghi and co-workers on the mutant Y73A showed that, by con-
trast to wild-type yFXN, this protein can spontaneously assemble
into larger oligomeric species in the absence of iron [ 39 ]. Thus, the
oligomerization behavior of yFXN depends on ﬁne details of the amino
acid sequence of the N-tail. Remarkably, data from the same group
indicate that the N-terminus of this protein is also highly ﬂexible [ 40 ].
In our case, although the N-tail of hFXN is predicted as an intrinsically
disordered segment [ 23 ], residues 66–75 display a lower tendency
to form disordered regions, by comparison to residues 45–61 and
76–90 (IUPRED [ 41 ] prediction shown in Fig. S9 ). We envision that
the N-terminal tail of hFXN may acquire a non-random conforma-
tion upon binding to other proteins inside the cell. The notion that
the N-terminal tail of hFXN56–210 might contain short interaction-
prone segments which could experience order / disorder transitions
upon speciﬁc binding is reinforced after taking into account the ca-
pability of peptide hFXN56–81 to acquire secondary structure in the
presence of co-solvents like TFE or SDS. The stabilization of two dif-
ferent conformations in each of these solvent conditions would also
be compatible with one of the distinctive features of IDPs, namely,
their ability to attain alternative structures in a template-dependent
fashion. This capability is attractively illustrated by the C-terminal
binding region of p53 [ 42 , 43 ]. 
Regarding hFXN81–210, the mature form of hFXN, is preponder-
antly found under physiological conditions, the excision of the N-
terminal tail in hFXN may be an important step precluding oligomer
assembly of hFXN in vivo . 
Very recently, some clues provided evidence for the existence of a
post-translational regulation mechanism of the hFXN level mediated
by the ubiquitin–proteasome system (UPS), thus opening the possi-
bility to hamper hFXN degradation by increasing its bioavailability in
FRDA [ 44 ]. However, in light of the results presented herein, it will be
essential to evaluate the level of intermediate states of hFXN and the
ability of these forms (and of the precursor) to trigger oligomeriza-
tion in vivo , in the presence of small molecules such as those used to
inhibit UPS-mediated degradation [ 44 ]. Finally, the extra mitochon-
drial isoform III of hFXN – lacking a 47 amino acid stretch (9–55) –
seems to be functionally relevant and might be implicated in FRDA.
This variant shares the same iron-catalyzed self-processing mecha-
nism of hFXN56–210 [ 45 ], perhaps preventing the aggregation of this
isoform mediated by its N-terminal tail. On the other hand, isoform
III might still keep the capability to interact with other cytoplasmic
proteins through its N-terminal tail. 
The presence of the conformationally plastic N-terminal tail might
impart hFXN the ability to act as a recognition signal as well as an
oligomerization trigger. Understanding the ﬁne tuning of these activ-
ities and the resulting balance will ultimately be relevant for under-
standing hFXN function in the cell. 
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H. Materials and methods 
.1. Peptide synthesis and puriﬁcation 
Peptide hFXN56–81, of sequence SSNQRGLNQIWN- 
KKQSVYLMNLRKS, was synthesized and partially puriﬁed by 
enScript Corp (Piscataway, NJ). The puriﬁcation was completed 
y HPLC (Rainin Dynamax, NY) using a reverse phase C18 semi- 
reparative column (Vydac) equilibrated in 0.05% aqueous TFA. The 
eptide was eluted with a linear gradient from 30% to 45% aqueous 
cetonitrile (ACN), 0.05% TFA. The peptide typically elutes at 31% 
CN. Fractions containing > 98.0% pure peptide were pooled and 
yophilized. Peptide concentration was calculated by measuring 
bsorbance in the near-UV region, using an extinction coefﬁcient: 
280nm = 6990 M −1 cm −1 . The molecular mass of peptide (theo- 
etical value: 3092.55 Da) was checked after HPLC by ESI-MS. As a 
ontrol sample, we had peptide FXN181–195 prepared of sequence 
LHELLAAELTKALKY (1800.11 Da), corresponding to the amphipathic 
-helix 2 of hFXN. In this case, a C-terminal Tyr tag was added to 
llow the concentration measurement by absorbance in the near-UV 
egion, using the extinction coefﬁcient: 280nm = 1490 M −1 cm −1 . 
GADIR prediction [ 33 , 46 , 47 ] based on the sequence of peptide 
FXN181–195 yields a low value of helical propensity: 5.8% helicity 
t 25 ◦C. 
.2. Protein expression and puriﬁcation 
Human frataxin cDNA was kindly provided by Dr. H `el ´ene Puccio 
rom IGBMC (Strasbourg, France). To prepare hFXN90–210, primers 
deI FXN90, tttaagaaggagatata catatg ctagatgagaccacctatgaa and XbaI 
XN210 gcatggatcctcaagcatcttttccggaataggc were used to amplify the 
DNA corresponding to the truncated version 90–210 of hFXN. The 
CR product was sub-cloned into a pET9b plasmid vector, and the 
dentity of the insert was conﬁrmed by DNA sequencing. E. coli BL21 
DE3) cells were then electroporated with this construction. Bacte- 
ia cultures (2–3 L Terriﬁc Broth, pH 7.2) were grown at 37 ◦C and 
80 rpm. hFXN90–210 was induced at OD = 1.0 by the addition of 
.0 mM IPTG to the culture medium (37 ◦C, 280 rpm). After induc- 
ion for 3.5 h, bacteria were centrifuged at 6000 rpm and the pellet 
as stored at −20 ◦C until rupture using a French press. Soluble and 
nsoluble fractions were separated by centrifugation at 10,000 rpm 
20 min). The soluble fraction was carefully loaded onto a preparative 
ephadex G-100 chromatography (SEC, 93 cm × 2.7 cm) column, pre- 
iously equilibrated with 20 mM Tris–HCl at pH 7.0 and 100 mM NaCl, 
 mM EDTA. Mass was conﬁrmed by ESI-MS (theoretical molecular 
ass value: 13,605.1 Da, considering the presence of the N-terminal 
et). To measure protein concentration, the extinction coefﬁcient 
sed for hFXN90–210 was 280nm = 26,930 M −1 cm −1 ( A 280nm = 1.98 
or a 1 mg / mL solution). 
To prepare hFXN56–210, primers NdeIFXN56 of sequence 
ttaagaaggagatata catatg agttcgaaccaacgtggcctcaa and XbaI FXN210 
ere used to amplify the cDNA corresponding to this variant. Sub- 
loning into pET9b and expression steps were identical to those pre- 
iously described for variant hFXN90–210. To purify hFXN56–210, we 
ook advantage of the increase in stability of the soluble aggregated 
orm of this variant by comparison to its monomeric form: the latter 
eing much more sensitive to protease action along expression and 
uriﬁcation. In this case, an ionic exchange chromatography (IE) was 
sed to clarify the soluble fraction (particularly, to reduce the DNA 
ontent). At pH 7.0, the hFXN56–210 does not bind to the DE52 ma- 
rix. Then, we performed a second IE in the same matrix at pH 8.0, 
 condition in which hFXN56–210 binds, thus allowing its straight- 
orward puriﬁcation. Finally, a step of size exclusion chromatogra- 
hy (SEC) using preparative Sephadex G-100 chromatography (SEC, 
3 cm × 2.7 cm) column, previously equilibrated with 20 mM Tris–
Cl at pH 7.0 and 100 mM NaCl, 1 mM EDTA was carried out (as in the case of hFXN90–210). In this case, fractions eluting at V o , contain- 
ing 95% pure hFXN56–210, were pooled and conserved at 4 ◦C until 
later use. The extinction coefﬁcient used for this variant to measure 
protein concentration was 280nm = 33,920 M −1 cm −1 ( A 280nm = 1.97 
for a 1 mg / mL solution); the molecular mass of hFXN56–210 was 
conﬁrmed by ESI-MS (theoretical molecular mass value: 17,255.3 Da, 
without considering the N-terminal Met). 
4.3. Fluorescence measurements 
Steady-state ﬂuorescence measurements were performed in a 
Jasco FP-6500 spectroﬂuorometer operating in the ratio mode and 
equipped with a thermostated cell holder connected to a circulating 
water bath set at 20 ◦C. To this end, a 1.0 cm path length cell sealed 
with a Teﬂon cap was used. When the intrinsic ﬂuorescence of pro- 
teins was measured, excitation wavelength was 295 nm and emission 
data were collected in the range 310–450 nm. The spectral slit-width 
was set to 3 nm for both monochromators. 
For ANS-binding experiments, hFXN variants (5 μM) in 20 mM 
Tris–HCl, 100 mM NaCl, pH 7.0 were incubated at room temperature 
(5 min), with the dye ANS (8-anilino-1-naphthalene sulfonic acid) at 
a ﬁnal concentration of 50 μM. A control sample consisting of ANS 
(50 μM) in buffer solution was prepared. The excitation wavelength 
was 350 nm and the emission spectra were collected between 400 
and 600 nm. The bandwidth used was 3.0 nm for both excitation 
and emission. In order to estimate the concentration of the dye, an 
extinction coefﬁcient value of 4,950 M −1 cm −1 at 350 nm was used 
[ 48 ]. 
4.4. Circular dichroism spectroscopy 
Ellipticity of protein samples was evaluated using a Jasco 810 
spectropolarimeter. Far-UV CD spectra were recorded in the range 
between 185 and 250 nm. A cell of 0.1 cm was used and protein con- 
centration was 10 μM. For near-UV CD spectra, the wavelength range 
was 240–340 nm, protein concentration was 20 μM, and the path 
length was 1.0 cm. In all cases data was acquired at a scan speed of 
20 nm / min and at least 3 scans were averaged for each sample. Blank 
scans were subtracted from the spectra and values of ellipticity were 
expressed in units of deg cm 2 dmol −1 , unless otherwise indicated in 
the text. Theoretical calculation of ellipticity for a 100% helical peptide 
was performed as explained by Luo and Baldwin [ 49 –51 ]. 
4.5. Limited trypsinolysis 
hFXN variants were incubated with trypsin 1:100 (pro- 
tein:protease, mass ratio) at 20 ◦C in 20 mM Tris–HCl, 100 mM NaCl, 
1 mM EDTA, pH 7.0. Aliquots were separated at different times (0, 
15, 30, and 45 min, 1, 2, and 16 h) and the reaction was immediately 
stopped by addition of the sample buffer for SDS–PAGE. Samples were 
kept at −20 ◦C until loaded into the gel. Proteolysis products were also 
analyzed by RP-HPLC followed by ESI-MS. 
4.6. Protein unfolding and oligomer disassembly experiments 
Isothermal unfolding experiments were carried out by incubat- 
ing the hFXN variants with 0–6 M GdmCl in buffer solution for 16 h 
at room temperature, followed by far UV CD analysis, tryptophan 
ﬂuorescence measurements, and SEC hydrodynamic radii determina- 
tion. To calculate thermodynamic parameters, a two-state unfolding 
mechanism was assumed, i.e. only native (N) and unfolded (U) species 
exist at equilibrium. In addition, a three-state model, considering na- 
tive (N), partially folded (I) and unfolded (U) species was also applied. 
Theoretical functions corresponding to each model were indepen- 
dently ﬁt to each data set [ 52 ]. GdmCl concentration was measured 
by refractometry. 
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 4.7. Hydrodynamic behavior 
Size exclusion chromatography. Changes in hydrodynamic volumes
were monitored by chromatography on a SEC-FPLC system equipped
with a 280 nm UV detector and a Superose 12 or a Superdex S-200 HR
10 / 30 columns (Pharmacia Biotech, Sweden), equilibrated at room
temperature in buffer solution, 20 mM Tris–HCl and 100 mM NaCl,
1 mM EDTA, pH 7.0. This type of chromatographic resin enabled us
to conﬁdently test for the presence of soluble aggregates in the sam-
ples. The ﬂow rate was 0.2 or 0.5 mL / min and the injection volume
was 100–200 μL. Samples were centrifuged at 14,000 rpm before
loading into the column that was previously calibrated with appro-
priate molecular weight markers. The hydrodynamic radius ( R S ) of
each species was derived from the elution volume ( V e ) considering
for that a calibration curve according Uversky [ 30 ]. 
4.8. Spectrophotometric determination of iron 
Iron concentration was determined using the method of 1,10-
phenanthroline [ 53 ]. Brieﬂy, 1,10-phenanthroline was prepared in
0.1 N HCl and a standard iron solution (18 mM) was prepared in
0.47 mM sulfuric acid for calibration curves. Ascorbic acid (100 μL,
10%) and sodium citrate (100 μL, 10%) were mixed with the protein
sample and water (up to a ﬁnal volume of 700 μL). After that, 1,10-
phenanthroline solution (100 μL) was added and mixed. After 15 min
incubation, the sample was centrifuged in a 1.5 mL Eppendorf tube at
maximum speed for 5 min. This centrifugation step is important to re-
move protein aggregates that disperse light, thus leading to incorrect
estimates. Next, the absorbance at 512 nm was read. 
4.9. Aggregation of hFXN56–210 induced by peptide hFXN56–81 
Variants hFXN90–210 and hFXN56–210 were incubated at 37 ◦C
in the presence or in the absence of peptide hFXN56–81, 1:10 (pro-
tein:peptide, molar ratio) in buffer 20 mM Tris–HCl and 100 mM NaCl,
1 mM EDTA, pH 7.0. Aliquots of the reactions were taken at different
incubation times (0, 1, 2, 3, 5 and 20 h). Samples were centrifuged for
10 min at 4 ◦C to isolate the soluble from the insoluble fractions and
the reaction was immediately stopped by addition of 4-fold concen-
trated sample buffer for SDS–PAGE. Then, samples were kept at −20 ◦C
until loaded into the gel. To evaluate the effect of TFE on oligomeriza-
tion and aggregation of hFXN56–210, protein samples (6.0 μM) were
incubated at room temperature in buffer 20 mM Tris–HCl, 100 mM
NaCl, 1 mM EDTA, pH 7.0 in the presence or in the absence of 20%
(v / v) TFE. After a short incubation time (5 min) the samples were
centrifuged (15 min at 4 ◦C) and the supernatants were analyzed by
UV absorption to determine protein concentration and by circular
dichroism to evaluate the secondary structure content. As running
experiments with TFE on the full proteins can be cumbersome, e.g.
TFE at relatively low concentration (20–25%) triggers aggregation of
a number of proteins, in this experiment hFXN90–210 was included
as a sample control. 
4.10. Bioinformatics, secondary structure, aggregation propensity and 
mutual information analysis 
Frataxin sequences (948) were obtained from PFAM and aligned
using SeaView (muscle algorithm). From the global alignment
(MSA 948 ), 165 sequences containing N-terminal extensions were se-
lected and a new MSA was performed (MSA 165 ). Mutual information
and conservation scores were calculated for both MSAs as in refer-
ences [ 54 –56 ]. Secondary structure predictions were calculated using
Jpred [ 31 , 57 ] on a MSA of 30 mammalian sequences ﬁshed by BLAST
by using hFXN1–210 as input. Helical stability was predicted using
the AGADIR algorithm [ 32 , 33 ]. Aggregation propensity was predictedusing the PASTA algorithm [ 36 ]. Prediction of intrinsically disordered
segments along the sequence of hFXN using IUPRED [ 41 ]. 
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